or
forgot password
  • cancer clinical trials in rochester, NY

  • Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Upstate NY Cancer Research and Education Foundation
    Rochester, New York 14623
    Lung Cancer, Non-small-cell Lung Carcinoma
    Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Head and Neck Neoplasms
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Esophageal Cancer
    A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
    Thomas O. McMeekin MD, PC

    Trial Locations
    Thomas O. McMeekin MD, PC
    The Center for Dermatology at Lifetime Health
    Skin Search and Dermatology Associates of Rochester
    Psoriasis
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Brain and Central Nervous System Tumors
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    University of Rochester Medical Center
    Rochester, New York 14642
    Multiple Myeloma
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Melanoma (Skin)
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Esophageal Cancer
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Rochester General Hospital/Lipson Cancer and Blood Center
    Rochester, New York 14621
    Myelodysplastic Syndrome, Iron Overload
    Safety Study to Evaluate FluMist in Immunocompromised Children
    University of Rochester School of Medicine & Dentistry
    Rochester, New York 14642
    Cancer
    Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
    University of Rochester Cancer Center
    Rochester, New York 14642
    Lymphoma, Non-Hodgkin, MALT Lymphoma
    S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lymphoma
    Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute GVHD.
    University of Rochester
    Rochester, New York 14642
    Graft vs Host Disease
    Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab
    University of Rochester Medical Center, James P. Wilmot Cancer Center

    Trial Locations
    University of Rochester Medical Center, James P. Wilmot Cancer Center
    Interlakes Foundation, Inc.
    Non-Hodgkin's Lymphoma
    Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
    University of Rochester Cancer Center
    Rochester, New York 14642
    Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
    Sleep Architecture and Chemotherapy-Related Fatigue
    University of Rochester James P. Wilmot Cancer Center
    Rochester, New York 14642
    Fatigue, Sleep, Cancer
    Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Lung Neoplasms
    Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Liver Neoplasms, Neoplasm Metastasis
    Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Cervix Neoplasm
    Measuring Alterations of DNA in Human Blood
    University of Rochester
    Rochester, New York 14642
    Neoplasms
    Radiation Dosimetry in Teeth
    University of Rochester, Dept. Radiation Oncology
    Rochester, New York 14642
    Radiation Tolerance
    Comparison of Educational Services and Outcomes for Patients Treated for Childhood Cancer
    University of Rochester Golisano Children's Hospital
    Rochester, New York 14642
    Cancer, Brain Tumor
    A Study For Using Radiosurgery On Limited Metastases
    University of Rochester Department of Radiation Oncology
    Rochester, New York 14642
    Neoplasms, Metastatic
    Study of Breath-holding as a Means to Reduce Tumor Motion From Breathing
    University of Rochester Department of Radiation Oncology
    Rochester, New York 14642
    Neoplasm, Metastatic
    Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence
    Smokers' Health Project
    Rochester, New York 14607
    Tobacco Use Disorder
    Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
    University of Rochester
    Rochester, New York 14642
    Multiple Sclerosis, Optic Neuritis, Transverse Myelitis, Acute Brainstem/Cerebellar Syndrome
    Group Therapy for Primary Breast Cancer
    University of Rochester CCOP
    Rochester, New York 14642
    Breast Cancer
    Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
    University of Rochester Medical Center
    Rochester, New York 14642
    Tumor Lysis Syndrome, Cancer, Hyperuricemia
    BI 2536 as Monotherapy in Treatment of Relapsed and Refractory Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Acupressure and Relaxation for Nausea Control
    University of Rochester James P. Wilmot Cancer Center
    Rochester, New York 14642
    Nausea
    Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Esophageal Cancer
    GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Colorectal Cancer
    Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Kidney Cancer
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lung Cancer
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    University of Rochester Medical Center

    Trial Locations
    University of Rochester Medical Center
    Interlakes Foundation Inc.
    Prostate Cancer
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    Strong Memorial Hospital
    Rochester, New York 14642
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lung Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    University of Rochester

    Trial Locations
    University of Rochester
    Interlakes Foundation Inc-Rochester
    Highland Hospital
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer